News
DONATE

Support Line: 833-275-4222

Walk to End Bladder Cancer

BCAN’s Partners in Progress

BCAN is proud to spotlight a pharmaceutical company partner that has shown outstanding commitment to supporting bladder cancer patients and their families. These dedicated partners play a vital role in advancing research, raising awareness, and improving the lives of those impacted by bladder cancer. Through their collaboration and shared vision, we continue to make strides toward better treatments, enhanced care and hope for a brighter future.

Click below to learn more about each partner’s commitment.

2026 Partners in Progress

  • CG Oncology

    At CG Oncology, they see a world where bladder cancer patients can benefit from their innovative immunotherapies to live with dignity and have an enhanced quality of life. Read more.

  • Ferring Pharmaceuticals

    Ferring Uro-Oncology is guided by a deep commitment to bringing better todays and more tomorrows to patients diagnosed with bladder cancer.  Learn more here.

  • AstraZeneca

    AstraZeneca has been advancing immunotherapy across several hard-to-treat cancers, and they are bringing that experience to bladder cancer, where additional options are still needed. Learn more.

2025 Partners in Progress

  • January – Ferring Pharmaceuticals

    Ferring Uro-Oncology is guided by a deep commitment to bringing hope and healing to patients diagnosed with bladder cancer.  Learn more here.

  • February – Photocure

    Recognizing the limitations faced by bladder cancer patients, Photocure strives to be “The Bladder Cancer Company,” prioritizing patient-centric solutions. Learn more here.

  • March – Ferring Uro-oncology

    Ferring Pharmaceuticals demonstrates a strong commitment to bladder cancer patients and families through their development of innovative therapies.  Learn more here.

  • June – CG Oncology

    CG Oncology sees a world where bladder cancer patients can benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. Read more here.

  • July – ImmunityBio

    The people of ImmunityBio work tirelessly to transform our living biological technologies into innovative treatments that will improve the lives of people around the world.

  • August – Ferring Pharmaceuticals

    Ferring believes in caring for the caregivers.  Read the moving account of Fran and her two biggest cheerleaders:  her husband, Dan. and her daughter, Erica.

  • September – UroGen Pharma

    UroGen Pharma is committed to elevating patient care by fundamentally changing the way urothelial, bladder, and specialty cancers are treated.

  • October – EMD Serono

    At EMD Serono, they apply their scientific curiosity to their commitment in tackling challenging tumor types in key areas.  Click here to learn more.

  • November – Johnson & Johnson

    Johnson & Johnson transformational medicines are developed with rigorous science and unwavering compassion to provide the greatest impact for patients.  Click here to learn more.

Thank you to all 2025 Partners in Progress sponsors for their generous support including the Astellas/Pfizer Alliance, CG Oncology, EMD Serono, Ferring Pharmaceuticals, Johnson and Johnson, Photocure and UroGen.

Related Stories